The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Prostate Cancer, Version 3.2024: Featured Updates to the NCCN Guidelines
Open accessAbstract
The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk stratification, initial management of very-low-risk disease, and the treatment of nonmetastatic recurrence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
D'Amico, A. V. (1998) · JAMA · doi:10.1001/jama.280.11.969 · Cited by 4,523
Self-citation10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
Hamdy, F. C., Donovan, J. L., Lane, J. A., Mason, M., Metcalfe, C., Holding, P., Davis, M., Peters, T. J., Turner, E. L., Martin, R. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606220 · Cited by 2,640
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
Donovan, J. L., Hamdy, F. C., Lane, J. A., Mason, M., Metcalfe, C., Walsh, E., Blazeby, J. M., Peters, T. J., Holding, P., Bonnington, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606221 · Cited by 1,338
Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
Simon, R. M., Paik, S., & Hayes, D. F. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp335 · Cited by 1,037
Castro, E., Goh, C., Olmos, D., Saunders, E., Leongamornlert, D., Tymrakiewicz, M., Mahmud, N., Dadaev, T., Govindasami, K., Guy, M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.1882 · Cited by 850
Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
Hamdy, F. C., Donovan, J. L., Lane, J. A., Metcalfe, C., Davis, M., Turner, E. L., Martin, R. M., Young, G. J., Walsh, E. I., Bryant, R. J., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2214122 · Cited by 823
Cuzick, J., Swanson, G. P., Fisher, G., Brothman, A. R., Berney, D. M., Reid, J. E., Mesher, D., Speights, V., Stankiewicz, E., Foster, C. S., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70295-3 · Cited by 792
Klein, E. A., Cooperberg, M. R., Magi-Galluzzi, C., Simko, J. P., Falzarano, S. M., Maddala, T., Chan, J. M., Li, J., Cowan, J. E., Tsiatis, A. C., et al. (2014) · European Urology · doi:10.1016/j.eururo.2014.05.004 · Cited by 659
Castro, E., Goh, C., Leongamornlert, D., Saunders, E., Tymrakiewicz, M., Dadaev, T., Govindasami, K., Guy, M., Ellis, S., Frost, D., et al. (2015) · European Urology · doi:10.1016/j.eururo.2014.10.022 · Cited by 368
D'Amico, A. V., Whittington, R., Malkowicz, S. B., Cote, K., Loffredo, M., Schultz, D., Chen, M., Tomaszewski, J. E., Renshaw, A. A., Wein, A., et al. (2002) · Cancer · doi:10.1002/cncr.10657 · Cited by 356
Self-citationCooperberg, M. R., Simko, J. P., Cowan, J. E., Reid, J. E., Djalilvand, A., Bhatnagar, S., Gutin, A., Lanchbury, J. S., Swanson, G. P., Stone, S., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.4396 · Cited by 351
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
Freedland, S. J., de Almeida Luz, M., De Giorgi, U., Gleave, M., Gotto, G. T., Pieczonka, C. M., Haas, G. P., Kim, C.-S., Ramirez-Backhaus, M., Rannikko, A., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2303974 · Cited by 319
Epstein, J. I., Amin, M. B., Fine, S. W., Algaba, F., Aron, M., Baydar, D. E., Beltran, A. L., Brimo, F., Cheville, J. C., Colecchia, M., et al. (2021) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0015-ra · Cited by 280
Self-citationEsteva, A., Feng, J., van der Wal, D., Huang, S.-C., Simko, J. P., DeVries, S., Chen, E., Schaeffer, E. M., Morgan, T. M., Sun, Y., et al. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00613-w · Cited by 217
Carter, H. B., Helfand, B., Mamawala, M., Wu, Y., Landis, P., Yu, H., Wiley, K., Na, R., Shi, Z., Petkewicz, J., et al. (2019) · European Urology · doi:10.1016/j.eururo.2018.09.021 · Cited by 215
Neal, D. E., Metcalfe, C., Donovan, J., Lane, J. A., Davis, M., Young, G., Dutton, S., Walsh, E. I., Martin, R. M., Peters, T. J., et al. (2019) · European Urology · doi:10.1016/j.eururo.2019.10.030 · Cited by 166
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer
Feng, F. Y.-C., Huang, H.-C. R., Spratt, D. E., Zhao, S. G., Sandler, H. M., Simko, J., Davicioni, E., Nguyen, P. L., Pollack, A. S., Efstathiou, J. A., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.7671 · Cited by 155
Self-citationArtificial intelligence predictive model for hormone therapy use in prostate cancer
Spratt, D. E., Tang, S., Sun, Y., Huang, H.-C., Chen, E., Mohamad, O., Armstrong, A. J., Tward, J. D., Nguyen, P. L., Lang, J. M., et al. (2023) · NEJM Evidence · doi:10.1056/evidoa2300023 · Cited by 153
Zelić, R., Garmo, H., Zugna, D., Stattin, P. E., Richiardi, L., Akre, O., & Pettersson, A. (2019) · European Urology · doi:10.1016/j.eururo.2019.09.027 · Cited by 138
Using PSMA imaging for prognostication in localized and advanced prostate cancer
Roberts, M. J., Maurer, T., Perera, M., Eiber, M. J., Hope, T. A., Ost, P., Siva, S., Hofman, M. S., Murphy, D. G., Emmett, L., et al. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00670-6 · Cited by 102
Dess, R. T., Suresh, K., Zeléfsky, M. J., Freedland, S. J., Mahal, B. A. V., Cooperberg, M. R., Davis, B. J., Horwitz, E. M., Terris, M. K., Amling, C. L., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.4922 · Cited by 89
Self-citationDal Pra, A., Ghadjar, P., Hayoz, S., Liu, V. Y. T., Spratt, D. E., Thompson, D. J. S., Davicioni, E., Huang, H.-C., Zhao, X., Liu, Y., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.05.007 · Cited by 65
Self-citationNguyen, P. L., Huang, H.-C. R., Spratt, D. E., Davicioni, E., Sandler, H. M., Shipley, W. U., Efstathiou, J. A., Simko, J., Pollack, A. S., Dicker, A. P., et al. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.12.035 · Cited by 61
Self-citationUpdate of the NCCN Guidelines for Treatment of Prostate Cancer
Millikan, R. E., & Logothetis, C. J. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62621-1 · Cited by 33
Canter, D. J., Reid, J., Latsis, M., Variano, M., Halat, S. K., Rajamani, S., Gurtner, K. E., Sangale, Z., Brawer, M. K., Stone, S., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.10.028 · Cited by 32
Ho, M. D., Ross, A. E., & Eggener, S. E. (2023) · The Journal of Urology · doi:10.1097/ju.0000000000003454 · Cited by 17
Attard, G., Parry, M., Grist, E., Mendes, L. S. T., Dutey‐Magni, P., Sachdeva, A., Brawley, C., Murphy, L. R., Proudfoot, J. A., Lall, S. K., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2488586/v1 · Cited by 15
Self-citationVince, R., Qi, J., Félix Rodríguez-Vidigal, F., Linsell, S. M., Johnson, A., Shetty, S. D., Hurley, P., Miller, D., George, A., Ghani, K. R., et al. (2021) · European Urology · doi:10.1016/s0302-2838(21)01382-8 · Cited by 5
Self-citation
Metadata
- Authors
- Schaeffer, E. M., Srinivas, S., Adra, N., An, Y., Bitting, R., Chapin, B., Cheng, H. H., D’Amico, A. V., Desai, N., Dorff, T., Eastham, J. A., Farrington, T. A., Gao, X., Gupta, S., Guzzo, T., Ippolito, J. E., Karnes, R. J., Kuettel, M. R., Lang, J. M., Lotan, T., McKay, R. R., Morgan, T., Pow-Sang, J. M., Reiter, R., Roach, M., Robin, T., Rosenfeld, S., Shabsigh, A., Spratt, D., Szmulewitz, R., Teply, B. A., Tward, J., Valicenti, R., Wong, J. K., Snedeker, J., & Freedman-Cass, D. A.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2024-04
- Volume
- 22
- Issue
- 3
- Pages
- 140-150
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W4394859735
- Cited by
- 312
- References
- 28
- FWCI
- 75.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.